Werner Milton H.
Insider CIK 1827621 · IKT President and CEO, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IKT Inhibikase Therapeutics, I | A Award deriv | 2025-01-21 | 2025-01-22 | 35,000 | — | $0 | 35,000 | SEC↗ |
| IKT Inhibikase Therapeutics, I | D To issuer deriv | 2025-01-21 | 2025-01-22 | 35,000 | — | $0 | 0 | SEC↗ |
| IKT Inhibikase Therapeutics, I | D To issuer deriv | 2025-01-21 | 2025-01-22 | 3,643 | — | $0 | 0 | SEC↗ |
| IKT Inhibikase Therapeutics, I | D To issuer deriv | 2025-01-21 | 2025-01-22 | 45,000 | — | $0 | 0 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2025-01-21 | 2025-01-22 | 45,000 | — | $0 | 45,000 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2025-01-21 | 2025-01-22 | 3,643 | — | $0 | 3,643 | SEC↗ |
| IKT Inhibikase Therapeutics, I | D To issuer deriv | 2025-01-21 | 2025-01-22 | 3,643 | — | $0 | 0 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2025-01-21 | 2025-01-22 | 20,834 | — | $0 | 20,834 | SEC↗ |
| IKT Inhibikase Therapeutics, I | D To issuer deriv | 2025-01-21 | 2025-01-22 | 20,834 | — | $0 | 0 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2025-01-21 | 2025-01-22 | 16,667 | — | $0 | 16,667 | SEC↗ |
| IKT Inhibikase Therapeutics, I | D To issuer deriv | 2025-01-21 | 2025-01-22 | 16,667 | — | $0 | 0 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2025-01-21 | 2025-01-22 | 3,643 | — | $0 | 3,643 | SEC↗ |
| IKT Inhibikase Therapeutics, I | D To issuer deriv | 2025-01-21 | 2025-01-22 | 3,643 | — | $0 | 0 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2025-01-21 | 2025-01-22 | 3,643 | — | $0 | 3,643 | SEC↗ |
| IKT Inhibikase Therapeutics, I | D To issuer deriv | 2025-01-21 | 2025-01-22 | 3,643 | — | $0 | 0 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2025-01-21 | 2025-01-22 | 3,643 | — | $0 | 3,643 | SEC↗ |
| IKT Inhibikase Therapeutics, I | D To issuer deriv | 2025-01-21 | 2025-01-22 | 3,643 | — | $0 | 0 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2025-01-21 | 2025-01-22 | 3,643 | — | $0 | 3,643 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2025-01-03 | 2025-01-07 | 2,207,671 | — | $0 | 2,207,671 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2025-01-03 | 2025-01-07 | 4,059,744 | — | $0 | 4,059,744 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2025-01-03 | 2025-01-07 | 5,315,056 | — | $0 | 5,315,056 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2024-04-01 | 2024-04-03 | 45,000 | — | $0 | 45,000 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2023-03-01 | 2023-03-03 | 210,000 | — | $0 | 210,000 | SEC↗ |
| IKT Inhibikase Therapeutics, I | P Buy | 2022-08-16 | 2022-08-16 | 5,000 | $0.80 | $4.0K | 5,335,433 | SEC↗ |
| IKT Inhibikase Therapeutics, I | P Buy | 2022-05-27 | 2022-05-31 | 5,000 | $0.98 | $4.9K | 5,330,433 | SEC↗ |
| IKT Inhibikase Therapeutics, I | P Buy | 2022-05-20 | 2022-05-23 | 10,000 | $0.60 | $6.0K | 5,325,433 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2022-03-07 | 2022-03-09 | 125,000 | — | $0 | 125,000 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2022-03-07 | 2022-03-21 | 125,000 | — | $0 | 125,000 | SEC↗ |
| IKT Inhibikase Therapeutics, I | M Exercise deriv | 2022-01-03 | 2022-01-04 | 21,853 | — | $0 | 0 | SEC↗ |
| IKT Inhibikase Therapeutics, I | M Exercise | 2022-01-03 | 2022-01-04 | 21,853 | $2.02 | $44.1K | 5,315,433 | SEC↗ |
| IKT Inhibikase Therapeutics, I | P Buy | 2021-11-17 | 2021-11-19 | 1,100 | $1.97 | $2.2K | 23,589 | SEC↗ |
| IKT Inhibikase Therapeutics, I | P Buy | 2021-11-17 | 2021-11-19 | 17,569 | $1.98 | $34.8K | 23,589 | SEC↗ |
| IKT Inhibikase Therapeutics, I | P Buy | 2021-11-17 | 2021-11-19 | 1,334 | $1.94 | $2.6K | 23,589 | SEC↗ |
| IKT Inhibikase Therapeutics, I | P Buy | 2021-11-17 | 2021-11-19 | 400 | $1.93 | $772 | 23,589 | SEC↗ |
| IKT Inhibikase Therapeutics, I | P Buy | 2021-11-17 | 2021-11-19 | 3,186 | $1.96 | $6.2K | 23,589 | SEC↗ |
| IKT Inhibikase Therapeutics, I | M Exercise deriv | 2021-08-17 | 2021-08-19 | 21,853 | — | $0 | 0 | SEC↗ |
| IKT Inhibikase Therapeutics, I | M Exercise | 2021-08-17 | 2021-08-19 | 21,853 | $2.02 | $44.1K | 5,293,580 | SEC↗ |
| IKT Inhibikase Therapeutics, I | M Exercise deriv | 2021-05-14 | 2021-05-18 | 43,707 | — | $0 | 0 | SEC↗ |
| IKT Inhibikase Therapeutics, I | F Tax w/h | 2021-05-14 | 2021-05-18 | 16,918 | $4.59 | $77.7K | 5,271,727 | SEC↗ |
| IKT Inhibikase Therapeutics, I | M Exercise | 2021-05-14 | 2021-05-18 | 43,707 | $0.38 | $16.6K | 5,288,645 | SEC↗ |
| IKT Inhibikase Therapeutics, I | A Award deriv | 2020-12-22 | 2020-12-29 | 100,000 | — | $0 | 100,000 | SEC↗ |